
Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category*
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- U.S. healthcare: consumer responses to viewing advertisements for medicines
- Drugs in development with potential to be first-in-class in 2016, by therapeutic area
- Small molecules facing loss of developed market exclusivity 2011-2020
- New medicine availability by therapy area in the U.S. 2013
- Medicinal market growth worldwide including rebates 2009-2018
- Medicinal market growth by world region, specialty and traditional 2013-2018
- Medicine doses consumed globally by region 2015 and 2020 forecast
- Biologics share of global pharmaceutical spending 2002-2017
- Median duration of drug shortages in Canada 2013-2016
- Italy: monthly value of medicaments imports 2017-2018
- Number of new drugs launched in the U.S. 2003-2015
- Market distribution of human insulin in hospitals in China 2018
- Italy: monthly value of medicaments of two or more constituents imports 2017-2018
- Breakdown of oral hypoglycemic drug sales in hospitals in China 2018-2030, by agent
- Mexico: public medicine expenditure 2012-2018, by supplier
- Availability of new medicines in Europe in 2018, by country
- Market share of ethical and OTC drugs in Vietnam 2018-2019
- Industry revenue of “pharmaceutical and medicine manufacturing“ in the U.S. 2012-2024
- Antibacterials for systemic use: consumption in Belgium 2018
- Level of confidence in medicine in France 2016, by type of drug
PhRMA. (December 15, 2020). Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category* [Graph]. In Statista. Retrieved February 27, 2021, from https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/
PhRMA. "Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category*." Chart. December 15, 2020. Statista. Accessed February 27, 2021. https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/
PhRMA. (2020). Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category*. Statista. Statista Inc.. Accessed: February 27, 2021. https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/
PhRMA. "Number of Biopharma Medicines in Development in The U.S. as of April 2020, by Select Therapeutic Category*." Statista, Statista Inc., 15 Dec 2020, https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/
PhRMA, Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category* Statista, https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/ (last visited February 27, 2021)